Mettrum Health Corp. Launches Premium Cannabis Oils Product Line

Agriculture Investing

Mettrum Health Corp. (TSXV:MT.V), a fully-integrated licensed producer of premium cannabis products, launched its much-anticipated line of Mettrum Cannabis Oils.As quoted in the press release: Mettrum Cannabis Oils will be priced at $90 for one 40 ml bottle, which contains the equivalent medicinal content of five grams of dried marijuana. Mettrum produces whole-flower cannabis extracts …

Mettrum Health Corp. (TSXV:MT.V), a fully-integrated licensed producer of premium cannabis products, launched its much-anticipated line of Mettrum Cannabis Oils.
As quoted in the press release:

Mettrum Cannabis Oils will be priced at $90 for one 40 ml bottle, which contains the equivalent medicinal content of five grams of dried marijuana. Mettrum produces whole-flower cannabis extracts using state-of-the art supercritical fluid CO2 extraction technology. The process extracts the major cannabinoids (THC and CBD), as well as the minor cannabinoids, terpenes and flavonoids that contribute to the overall medicinal value of medical cannabis. The result of this process is a highly concentrated resin. This extract is then suspended in an oil to make it easier to administer orally. Mettrum uses medium chain triglyceride oil (MCT) in our formulations. MCT is naturally occurring and used widely in the food, pharmaceutical and natural products industry. It is highly stable, flavourless, odourless, and allows for increased absorption making it ideal to use in cannabis oils.
Today, Mettrum is launching three oils in the Red, Blue, and Yellow categories, in line with the Mettrum Spectrum™, a trademarked system that helps physicians and their patients select the cannabis strain or strains that are most appropriate for their particular medical need. The Mettrum Spectrum™ allows for the categorization of medical cannabis products based on different ratios of key medicinal cannabinoids: cannabidiol (CBD) and tetrahydrocannabinol (THC). The Blue and Yellow category oils are notably unique as they are derived from rare strains of cannabis with a high ratio of CBD to THC ̶ making them a relevant treatment for an expanded population of prospective patients. In the coming weeks, additional products will be added to broaden the selection across the categories that make up the Mettrum Spectrum™.
The launch comes on the heels of the announcement that Mettrum received a license from Health Canada for the production of cannabis at its new 60,000-square-foot production facility in Bowmanville, Ontario.

Mettrum Health CEO, Michael Haines, stated:

As Canada’s second LP to receive a license to sell cannabis extracts, we’ve been working hard to deliver accessibly priced, premium oils for our clients. We are responding to the demand from patients and health care professionals alike for alternative consumption methods of medical cannabis.

The Conversation (0)
×